Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection.
about
Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village.HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007.Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?Protection versus pathology in aviremic and high viral load HIV-2 infection-the pivotal role of immune activation and T-cell kinetics.Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis.Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West AfricaAre plasma biomarkers of immune activation predictive of HIV progression: a longitudinal comparison and analyses in HIV-1 and HIV-2 infections?Potent autologous and heterologous neutralizing antibody responses occur in HIV-2 infection across a broad range of infection outcomes.For protection from HIV-1 infection, more might not be better: a systematic analysis of HIV Gag epitopes of two alleles associated with different outcomes of HIV-1 infection.Clinical predictors cannot replace biological predictors in HIV-2 infection in a community setting in West AfricaHIV-2 and its role in conglutinated approach towards Acquired Immunodeficiency Syndrome (AIDS) Vaccine DevelopmentHIV-1 and HIV-2 differentially mature plasmacytoid dendritic cells into IFN-producing cells or APCs.The presence of prolines in the flanking region of an immunodominant HIV-2 gag epitope influences the quality and quantity of the epitope generated.Higher homologous and lower cross-reactive Gag-specific T-cell responses in human immunodeficiency virus type 2 (HIV-2) than in HIV-1 infectionGag-specific CD4+ T-cell frequency is inversely correlated with proviral load and directly correlated with immune activation in infection with human immunodeficiency virus type 2 (HIV-2) but not HIV-1.Identification of Host Micro RNAs That Differentiate HIV-1 and HIV-2 Infection Using Genome Expression Profiling TechniquesElevated levels of invariant natural killer T-cell and natural killer cell activation correlate with disease progression in HIV-1 and HIV-2 infections.Special anniversary review: twenty-five years of human immunodeficiency virus research: successes and challenges.Tenets of protection from progression to AIDS: lessons from the immune responses to HIV-2 infection.CD4+ T cells with an activated and exhausted phenotype distinguish immunodeficiency during aviremic HIV-2 infection.Downregulation of the T-cell receptor by human immunodeficiency virus type 2 Nef does not protect against disease progression.An underestimated lentivirus model: what can HIV-2 research contribute to the development of an effective HIV-1 vaccine?Justification for the inclusion of Gag in HIV vaccine candidates.Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2-Infected Controllers.Cohort Profile: The Bissau HIV Cohort-a cohort of HIV-1, HIV-2 and co-infected patients.Comprehensive analysis of HIV Gag-specific IFN-gamma response in HIV-1- and HIV-2-infected asymptomatic patients from a clinical cohort in The Gambia.HLA-associated polymorphisms in the HIV-2 capsid highlight key differences between HIV-1 and HIV-2 immune adaptation.Infants with late breast milk acquisition of HIV-1 generate interferon-gamma responses more rapidly than infants with early peripartum acquisition.Highly avid, oligoclonal, early-differentiated antigen-specific CD8+ T cells in chronic HIV-2 infectionGenetic diversity and molecular epidemiology of HIV transmission
P2860
Q33919925-41286E62-0B1E-4766-AB01-342530DDD89CQ33951633-1BA4321F-101A-4EEE-B45C-264347B1F10CQ33992829-8CC839D0-12C7-4F36-88F9-24BC4A6F1EBFQ34034072-05862F39-D3B3-4833-AFE7-EF291AAB527AQ34035802-7F16D01B-BCA5-490A-9B32-3749CC849C0FQ34046201-622CD7E7-5CD3-4D4B-852D-BAD6B8FC2349Q34412376-38B4D01A-8D7A-4E28-8EE0-FD1AE57E443BQ35665765-32F19521-7BE7-40B9-A4DE-F623135D10E2Q35665770-13C23D53-F009-4C50-A760-2346F48DD99DQ35884346-C42D246C-93EB-452F-85BB-4B729C996366Q36651031-225D5E75-A8D6-4C9E-87D4-63330B50FA7FQ36770954-19873EF2-8BF9-4010-A7C0-B57BE52BBF22Q36799875-02572CD3-5228-4E14-9B1D-2B42CE1C2360Q36845911-ECDC23F1-3A98-4075-BD85-4C0545B8F50DQ36898820-07704993-1226-4038-97F9-5BBC90405847Q36946996-6CADB0A9-0A7B-42F0-A45E-37A044B9DB91Q37048079-566193D1-916F-438A-B4C6-BEB15EFF837FQ37121901-1319B510-2750-4106-844F-BBA764CCAB3CQ37130458-1AD29FE4-0BA5-445C-A055-B202A2A565A9Q37312729-4D144FA0-55D8-494D-9F45-D4CF07368E86Q37452520-4490B6F6-E402-494D-906B-0A70DCEF7F27Q37845847-FFED9FE7-FFC7-4B38-B74C-6E0F06CD9748Q38662319-F96E013F-98E9-4CF7-9310-C9D9D5F93271Q39448439-F55648EC-2A61-46D2-8E4E-9F297BE378A3Q41689888-5C206004-F7FF-42CC-B86F-E6C847A0DC46Q44457386-BE417C80-5972-48CF-92E6-DF5FA40C394EQ47549002-29E4CB30-674C-4094-9ED6-1C6B095FE4ADQ47812016-129DDA3B-B613-4BDB-8AEF-A1C115AE47B9Q56787219-8439E7B6-F4FC-440E-9CE0-2EA3E15EAE82Q57196807-2F140FAB-C7CF-495E-9293-51C2FB188A4D
P2860
Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection.
@ast
Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection.
@en
type
label
Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection.
@ast
Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection.
@en
prefLabel
Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection.
@ast
Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection.
@en
P2093
P2860
P50
P356
P1476
Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection.
@en
P2093
Abraham Alabi
Andrew McMichael
Assan Jaye
Carlos da Costa
Hilton Whittle
Ramu Sarge-Njie
Sarah Rowland-Jones
Tim Vincent
P2860
P304
P356
10.1172/JCI32380
P407
P577
2007-10-01T00:00:00Z